十一月 2025
- Home
- Immatics
十一月 2025的Immatics市场份额分析
Prof. Dr. med. Dirk Busch joined Immatics Scientific Advisory Board in 2021. Dirk Busch studied human medicine at the Universities of Mainz and Freiburg, and completed his doctor’s degree in medicine in 1993. Dirk Busch studied human medicine at the Universities of Mainz and Freiburg, and completed his doctor’s degree in medicine in 1993. This was followed by his residency and postdotoral studies at the Children’s Hospital of the University of Würzburg from 1994 until 1996 and at the Section of Infectious Diseases and Immunobiology at the Yale University in New Haven/USA from 1996 until 1999. From there he joined the Technical University of Munich (TUM) where he finished in 2005 his clinical specialization in Medical Microbiology and Infection Epidemiology, and started his own independent research work as principal investigator. He gained his habilitation from TUM in 2001. From 2004 until 2008 he was C3-Professor for Medical Microbiology and Immunology […]
Immatics(包含公司地区分支机构)
查看更多网站流量和参与度信息- immatics.com
Immatics收入截至 十一月 2025为 50M - 75M
Immatics主要域名产生的收入
3 年中Immatics主要域名的收入
Immatics主要域名的收入
Immatics热门域名的总访问量
了解Immatics市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Immatics热门域名的平均访问时长
分析Immatics参与度指标。
过去 3 个月的平均访问时长
子公司明细
Immatics热门域名的平均页面浏览量
了解Immatics如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Immatics 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Immatics Biotechnologies GmbH hired Amie Krause as Chief Human Resources Officer on Oct 27th '25.Amie Krause joins Immatics from Dompé, where she served as Chief Human Resources Officer.
十月 27, 2025阅读更多
新闻Immatics Biotechnologies GmbH hired Venkat Ramanan as Chief Financial Officer on Oct 1st '25.Houston, Texas and Tuebingen, Germany, October 1, 2025 - Immatics N.V. (NASDAQ: IMTX, "Immatics" or the "Company"), a clinical-stage biopharmaceutical company and the global leader in precision targeting of PRAME, today announced the appointment of Venkat Ramanan, Ph.D., as Chief Financial Officer ("CFO"), effective immediately.
十月 1, 2025阅读更多
新闻Immatics Biotechnologies GmbH launches IMA203 TCR T-cell Therapy data at 2025 ASCO Annual Meeting.Immatics (NASDAQ: IMTX) has announced upcoming presentations of its IMA203 TCR T-cell therapy at the 2025 ASCO Annual Meeting in Chicago.
四月 23, 2025阅读更多
查看 Immatics 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。